PeterALeoneMD

Infectious Disease • Chapel Hill, NC

Professor of Medicine

Join to view full profile

Dr. Leone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leone's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27514
Phone+1 919-966-4996

Fax+1 919-843-5515

Education & Training

Wake Forest University Baptist Medical CenterFellowship, Infectious Disease, 1985 - 1988
Summa Health System/NEOMEDResidency, Internal Medicine, 1982 - 1985
Northeast Ohio Medical UniversityClass of 1982

Certifications & Licensure

NC State Medical License 1988 - 2025
OH State Medical License 1984 - 1992
American Board of Internal Medicine Internal Medicine

Clinical Trials

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
Completed
Phase 2

Publications & Presentations

PubMed

8 citations
Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.
Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa
Open Forum Infectious Diseases. 2023-03-01
1 citations
Progression of a large syphilis outbreak in rural North Carolina through space and time: Application of a Bayesian Maximum Entropy graphical user interface.
Lani C Fox, William C Miller, Dionne Gesink, Irene Doherty, Kristen H Hampton
PLOS Global Public Health. 2023-01-01
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppressi...
Olayemi Osiyemi, Stéphane De Wit, Faïza Ajana, Fiona Bisshop, Joaquín Portilla
Clinical Infectious Diseases. 2022-09-29

Journal Articles

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial
David I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases

Press Mentions

What Are the Symptoms of Anal Chlamydia?May 11th, 2021
After Your Shot: Lesson Learned from Covid 19February 23rd, 2021
Herpes Is A Common Virus. Why Do We Treat It like the Plague?December 4th, 2020
Join now to see all

Grant Support

The Stop StudyNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2010
Clinical Trial: Gd-Alum/Mpl Vaccine In The Prevention Of Genital Herpes In YoungNational Center For Research Resources2008
Gd-Alum/Mpl Vaccine In The Prevention Of Genital Herpes In Young WomenNational Center For Research Resources2004–2007
Acyclovir Levels In Semen During And Following Oral Admin Of ValaciclovirNational Center For Research Resources2005